ABSTRACT
We describe a case of a 25-year-old female with an acute left otomastoiditis, accompanied by a left temporal extradural abscess with moderate perifocal edema and meningitis. Intravenous meropenem (2 g 8-hourly) and intravenous methylprednisolone (40 mg once daily) were commenced empirically. Teicoplanin (400 mg once daily intravenously) was added after 5 days when culture results were available. Teicoplanin was discontinued on day 25 but meropenem and methylprednisolone were continued for a further 15 days, after which the abscess completely resolved without sequelae. No treatment-induced adverse effects or seizures were observed. Thus, in selected patients, antibacterials (in conjunction with a corticosteroid) may be successfully used without surgery to treat brain abscesses and in such circumstances meropenem is a useful option for empiric therapy.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Brain Abscess/drug therapy , Drug Therapy, Combination/therapeutic use , Mastoiditis/complications , Meningitis/drug therapy , Thienamycins/therapeutic use , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Brain Abscess/diagnostic imaging , Brain Abscess/etiology , Brain Edema/diagnostic imaging , Brain Edema/drug therapy , Brain Edema/etiology , Drug Therapy, Combination/administration & dosage , Female , Humans , Injections, Intravenous , Meningitis/diagnostic imaging , Meningitis/etiology , Meropenem , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Teicoplanin/administration & dosage , Teicoplanin/therapeutic use , Thienamycins/administration & dosage , Tomography, X-Ray ComputedABSTRACT
The authors report their experience on the use of oral suspension of Clarithromycin in respiratory infections in the pediatric age. Thirty-three patients affected by various infectious pathologies of the respiratory tract, treated with oral Clarithromycin at the dosage of 15 mg/kg/day, were studied. The therapeutic outcome was very encouraging, the drug well tolerated and without side effects.
